Skip to Content

Ketoconazole topical Pregnancy and Breastfeeding Warnings

Ketoconazole topical is also known as: Extina, Ketodan, Kuric, Nizoral A-D, Nizoral Shampoo, Nizoral Topical, Xolegel

Ketoconazole topical Pregnancy Warnings

Animal studies with high-dose oral ketoconazole have revealed evidence of teratogenicity and embryotoxicity; this reproductive toxicity was at doses not relevant to topical use of this drug. Syndactylia and oligodactylia occurred in rats given 80 mg/kg/day of oral ketoconazole (10 times the maximum recommended human oral dose) and embryotoxicity occurred at 160 mg/kg/day; such effects may be due to maternal toxicity, which was observed at these dose levels. There are no controlled data in human pregnancy; limited data indicate no adverse effects of this topical drug on pregnancy or on fetal/neonatal health. There are no known risks associated with use of this drug during pregnancy; no effects on the neonate expected. This drug has not been detected in plasma after topical application to the skin or chronic shampooing on the scalp of nonpregnant patients; plasma drug levels were detected after the shampoo was applied topically to the entire body. AU TGA pregnancy category B3: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus; caution is recommended. AU TGA pregnancy category: B3 US FDA pregnancy category: C

See references

Ketoconazole topical Breastfeeding Warnings

Use is generally considered acceptable; caution is recommended. -Cream: According to some authorities, a decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: -Little to no risk to the breastfed infant expected with maternal use (as shampoo or topically on the skin); however, topical application on the breast or nipples should be avoided due to possible ingestion by the infant and availability of safer alternatives. -Ointments should not be applied to the breast prior to breastfeeding; water miscible cream or gel products should be used if necessary.

There are no known risks associated with use of this drug during lactation; no effects on the nursing infant expected. It is unknown if there is sufficient systemic absorption with topical use of this drug to have detectable quantities in breast milk. This drug has not been detected in plasma after topical application to the skin or chronic shampooing on the scalp; plasma drug levels were detected after the shampoo was applied topically to the entire body.

See references

References for pregnancy information

  1. Melbourne: Therapeutic Guidelines Limited "eTG complete [Online] Available from: URL: http://online.tg.org.au/complete/desktop/tgc.htm." ([2014, Nov -]):
  2. "Product Information. Nizoral (ketoconazole)." Janssen Pharmaceutica, Titusville, NJ.
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

References for breastfeeding information

  1. Melbourne: Therapeutic Guidelines Limited "eTG complete [Online] Available from: URL: http://online.tg.org.au/complete/desktop/tgc.htm." ([2014, Nov -]):
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  3. "Product Information. Nizoral (ketoconazole)." Janssen Pharmaceutica, Titusville, NJ.
  4. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide